XML 34 R22.htm IDEA: XBRL DOCUMENT v3.21.2
Equity Incentive Plans and Stock-Based Compensation (Tables)
9 Months Ended
Sep. 30, 2021
Disclosure Of Compensation Related Costs Sharebased Payments [Abstract]  
Summary of Option Activity

The following table summarizes the option activity for the nine months ended September 30, 2021:

 

 

 

Options

 

 

Weighted-
Average
Exercise
Price

 

 

Weighted-
Average
Remaining
Contractual
Term
(in years)

 

 

Aggregate
Intrinsic
Value
(in thousands)

 

Outstanding at December 31, 2020

 

 

3,996,174

 

 

$

9.03

 

 

 

8.5

 

 

$

99,107

 

Granted

 

 

1,534,842

 

 

 

27.42

 

 

 

 

 

 

 

Exercised

 

 

(61,768

)

 

 

2.86

 

 

 

 

 

 

 

Forfeited and cancelled

 

 

(209,302

)

 

 

21.20

 

 

 

 

 

 

 

Outstanding at September 30, 2021

 

 

5,259,946

 

 

$

13.99

 

 

 

8.2

 

 

$

47,735

 

Exercisable at September 30, 2021

 

 

2,149,552

 

 

$

6.34

 

 

 

7.3

 

 

$

31,542

 

Summary of Outstanding Shares of Potential Dilutive Securities Excluded from Computation of Diluted Net Loss per Share

The following outstanding shares of potentially dilutive securities were excluded from the computation of diluted net loss per share attributable to common stockholders for the periods presented because including them would have been anti-dilutive:

 

 

Three Months Ended September 30,

 

 

Nine Months Ended September 30,

 

 

2021

 

 

2020

 

 

2021

 

 

2020

 

Options to purchase common stock

 

5,259,946

 

 

 

3,959,693

 

 

 

5,259,946

 

 

 

3,959,693

 

Total

 

5,259,946

 

 

 

3,959,693

 

 

 

5,259,946

 

 

 

3,959,693

 

Summary of Fair Value of Stock Options Estimated Using Black-Scholes Merton Option Pricing Model Assumptions

The fair value of stock option awards to employees, executives, directors, and other service providers was estimated at the date of grant using the Black-Scholes Merton option pricing model with the following assumptions:

 

 

 

Nine Months Ended
September 30,

 

 

2021

 

2020

Stock price

 

$16.61 - $35.67

 

$16.00 - $35.92

Risk-free interest rate

 

0.60% - 1.15%

 

3.17% - 4.45%

Expected volatility

 

82.88% - 88.43%

 

88.01% - 95.11%

Expected term (in years)

 

5.50 - 6.08

 

5.50 - 6.08

Expected dividend yield

 

0%

 

0%

Summary of Total Stock-based Compensation Expense

The table below summarizes the total stock-based compensation expense included in the Company’s statements of operations and comprehensive loss for stock options for the periods presented (in thousands):

 

 

Three Months Ended
September 30,

 

 

Nine Months Ended
September 30,

 

 

2021

 

 

2020

 

 

2021

 

 

2020

 

Research and development

$

1,250

 

 

$

592

 

 

$

3,608

 

 

$

1,406

 

General and administrative

 

2,147

 

 

 

1,089

 

 

 

5,746

 

 

 

2,183

 

Total stock-based compensation expense

$

3,397

 

 

$

1,681

 

 

$

9,354

 

 

$

3,589